These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 861140)

  • 1. Cerebrospinal fluid concentration of metoprolol in a hypertensive patient.
    WOOD AJ
    Br J Clin Pharmacol; 1977 Apr; 4(2):240-1. PubMed ID: 861140
    [No Abstract]   [Full Text] [Related]  

  • 2. beta-Adrenoreceptor-blocking agents and the blood-brain barrier.
    Cruickshank JM; Neil-Dwyer G; Cameron MM; McAinsh J
    Clin Sci (Lond); 1980 Dec; 59 Suppl 6():453s-455s. PubMed ID: 7449299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect and concentration in plasma of metoprolol after administration in the morning and in the evening in essential hypertension].
    Edvardsson N; Fritz H; Hällén J; Larsson R; Norlander S; Rasmussen PA
    Lakartidningen; 1978 Mar; 75(11):1069-72. PubMed ID: 345028
    [No Abstract]   [Full Text] [Related]  

  • 4. Disposition of metoprolol in the newborn.
    Lundborg P; Agren G; Ervik M; Lindeberg S; Sandstrom B
    Br J Clin Pharmacol; 1981 Oct; 12(4):598-600. PubMed ID: 7295496
    [No Abstract]   [Full Text] [Related]  

  • 5. A pharmacokinetic comparison between different slow-release formulations of metoprolol (Lopresor SR and Betaloc SA).
    Browning RC; John VA; Till RJ; Theobald W
    Br J Clin Pharmacol; 1981 Oct; 12(4):600-2. PubMed ID: 7295497
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effects of metoprolol and a combination of metoprolol and hydrochlorothiazide on arterial tension values in hypertensive patients at rest and following exertion. Crossed double-blind study].
    Novo S; Davì G; Avellone G; Fazio M; Micci S; Modica R; Buzzetti G
    Boll Soc Ital Cardiol; 1981; 26(2):117-29. PubMed ID: 7337767
    [No Abstract]   [Full Text] [Related]  

  • 7. Experiences with metoprolol Durules, a slow-release formulation in hypertension.
    Tuomilehto J; Nissinen A
    J Int Med Res; 1980; 8(1):44-9. PubMed ID: 7358203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Verapamil-hydrochlorothiazide vs. metoprolol-hydrochlorothiazide. Trial in hypertensive patients].
    de Oliveira JM
    Arq Bras Cardiol; 1981 Mar; 36 Suppl 1():33-5. PubMed ID: 7034699
    [No Abstract]   [Full Text] [Related]  

  • 9. Sustained release metoprolol: a comparison with conventional formulation in the treatment of hypertension.
    Logan RL; Goldstraw PW; Kiddle GB; Flacks LM; Watt M
    N Z Med J; 1981 Jul; 93(687):1-2. PubMed ID: 7022275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of metoprolol and of the combination of metoprolol and hydrochlorothiazide arterial hypertension patients].
    Strano A; Novo S; Salvia A
    Boll Soc Ital Cardiol; 1980; 25(4):333-45. PubMed ID: 7284139
    [No Abstract]   [Full Text] [Related]  

  • 11. Once-daily metoprolol in primary hypertension.
    Karlberg BE; Nilsson O; Tolagen K; Nitelius E; Waern U
    Clin Pharmacol Ther; 1979 Apr; 25(4):399-407. PubMed ID: 371902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atenolol and metoprolol once daily in hypertension.
    Scott AK; Rigby JW; Webster J; Hawksworth GM; Petrie JC; Lovell HG
    Br Med J (Clin Res Ed); 1982 May; 284(6328):1514-6. PubMed ID: 6805588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-blockers: once or three times a day?
    Reybrouck T; Amery A; Fagard R; Jousten P; Lijnen P; Meulepas E
    Br Med J; 1978 May; 1(6124):1386-8. PubMed ID: 348260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metoprolol administered once daily in the treatment of hypertension. A double-blind crossover comparison between conventional tablets and metoprolol Durules.
    Asplund J; Ohman P
    Ann Clin Res; 1981; 13 Suppl 30():30-6. PubMed ID: 7027891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of short-term and long-term treatment with metoprolol on renal blood flow and glomerular filtration rate in hypertensive patients with a normal kidney function.
    Strandgaard S; Elmgreen J; Christensen TE; Laursen SW
    Dan Med Bull; 1982 Oct; 29(6):287-9. PubMed ID: 7140383
    [No Abstract]   [Full Text] [Related]  

  • 16. Metoprolol with and without chlorthalidone in hypertension.
    Kubik M; Kendall M; Ebbutt A; John V
    Clin Pharmacol Ther; 1979 Jan; 25(1):25-32. PubMed ID: 363333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hemodynamic changes under metoprolol compared to propranolol in hypertensive patients].
    Pfisterer M; Burkart F; Bühler FR; Schweizer W
    Schweiz Med Wochenschr; 1976 Nov; 106(45):1567-9. PubMed ID: 1013675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pharmacodynamic effectiveness of metoprolol in adolescent hypertension.
    Falkner B; Lowenthal DT; Affrime MB
    Pediatr Pharmacol (New York); 1982; 2(1):49-55. PubMed ID: 7110756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metoprolol in hypertension: an open evaluation.
    Assaykeen TA; Michell G
    Med J Aust; 1982 Jan; 1(2):73-7. PubMed ID: 7040924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical study of metoprolol in the treatment of constant essential hypertension].
    Peltier JM
    LARC Med; 1982; 2(7):611-2. PubMed ID: 7167036
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.